OR WAIT 15 SECS
Interactive Clinical Technologies Incorporated, (ICTI) is pleased to announce two recent promotions.
April 28, 2005, Yardley, PA - Interactive Clinical Technologies Incorporated, (ICTI) is pleased to announce two recent promotions.
Valarie L. Higgins has been appointed Vice President, Clinical Services. Since joining ICTI six years ago, she has served in increasingly important positions in clinical operations management. Her contributions have been instrumental in establishing ICTI's reputation for high-quality customer service. Most recently Ms Higgins was Director, Clinical Services at ICTI. Earlier in her career, she was a Research Assistant for Covance. Ms. Higgins holds a BA in Psychology from Rutgers University.
Marsha B. Rehrer has been promoted to Director, Software Testing Services, from Associate Director. Throughout her career, Ms. Rehrer has held positions of expanding responsibility in software development, quality assurance and operations. Her recent promotion recognizes the value she has brought and will continue to bring to ICTI's growing product base. Ms. Rehrer holds a BS in English from Davis & Elkins College in Elkins, WV.
Richard McCann, President of ICTI, noted. "To continue to provide our clients unparalleled service and software, we need highly qualified, talented individuals at all levels of our company. I am pleased that Val and Marsha will have increased influence on our quality and service."
About ICTI and Almac Sciences
ICTI is a division of Almac Sciences that specializes in interactive solutions to accelerate the clinical trials process and reduce the costs of clinical trials. Our solutions include Interactive Voice Response (iVR) for patient randomization, dosing and clinical supply management; phone-based patient diaries; iTrial EDC for clinical trials data; and forecasting for clinical trials supplies planning.
Almac Sciences and its affiliated companies (CSS (Chemical Synthesis Services), CTS (Clinical Trial Services), ICTI (Interactive Clinical Technologies Incorporated), PDMS (Pharmaceutical Development and Manufacturing Services) and ArraDX (Array Based Diagnostics)) provide a broad range of services across drug discovery, diagnostics, pharmaceutical research and development, manufacture of API, clinical trials and drug product manufacture. US operations are based in Pennsylvania, North Carolina and California. European operations are headquartered in Craigavon, Northern Ireland with additional operations in London and Edinburgh.